Critics of co-pay coupons allege these payments allow branded manufacturers to circumvent incentives to encourage the use of lower-cost alternatives. With increased use of these coupons, as well as several high-profile cases in the courts, it is timely to explore the economic effects of co-pay coupons and consider a framework for assessing their impact. Click the link below to read more.
Rare disease PMA trends in France: Price achieved vs. disease prevalence
In this installment, we examine the relationship between launch prices in France and disease prevalence as reported in the Haute Autorité de Santé assessments.


